The acomplia aventis rimonabant sanofi results were broadly in line with our expectations. Pfizer, Bayer, Eli Lilly and Merck are developing treatments similar to Acomplia, though they are further behind.

We highlight that the RIO-diabetes patient population was limited to patients given only one prior treatment with one hypoglycemic agent. It is expected to draw nearly $18 billion in Acomplia aventis rimonabant sanofi global sales this year, and up to $28. 4 billion next year, according to Morgan Stanley projections.

The new acomplia aventis rimonabant sanofi data comes from Sanofi-Aventis' first non-obesity trial with Acomplia. The results of the six month trial, dubbed Serenade, were presented at the International Diabetes Federation World Diabetes Congress in Cape Town, South Africa. Results showed improvements in cholesterol levels among patients taking the 20mg Acomplia aventis rimonabant sanofi dose, as well as promising data on weight loss and smoking cessation. It is the first of a new generation of drugs set to hit the market in the next few years that could transform obesity, still a small market, into a gold mine for the pharmaceutical industry. "This is the prototype of a new class of compounds;' endocrinologist Robert Eckel of the University of Colorado Health Sciences Center in Denver said at the heart meeting. Throughout the study, investigators recorded the Acomplia aventis rimonabant sanofi volunteers' weight, blood concentrations of cholesterols, and other indicators of metabolic health. The Committee for Medicinal Products for Human Use (CMPH), an advisory group to the European medical regulator EMEA, recommended on 28 April that Acomplia be approved for obese patients, as well as for overweight people acomplia aventis rimonabant sanofi with Type 2 diabetes or dyslipidemia, both of which are conditions that governments usually fund. Neither can be acomplia aventis rimonabant sanofi prescribed for any indications beyond weight loss. We understand that there is a strong Acomplia aventis rimonabant sanofi probability that Sanofi-Aventis will not initially apply for a primary indication for diabetes until further trials in a wider diabetes patient population have been concluded. But the drug's benefits may go beyond just smokers and obese people, researchers say.
Acomplia aventis rimonabant sanofi those whose pills were switched regained much of their lost weight. The expected green light from Brussels in the next few weeks would mean that the French giant Sanofi-Aventis could begin marketing the treatment, called rimonabant but branded as Acomplia, later this summer. And 8 Canadian institutions enlisted more than 3,000 obese volunteers, mostly women, who agreed to take a daily pill while attempting to diet for 2 years. During the first year, two-fifths of the volunteers took 20 milligrams per day of rimonabant, a similar number took 5 mg/day, and the rest took a placebo pill. Neither Orlistat nor Meridia qualify for reimbursement with US insurers.
The body has its own marijuana-like substances called endocannabinoids, and they activate certain brain cells that in turn can lead to stimulation of the brain's reward system. Rimonabant's versatility traces back to its effects on the brain's reward system, circuitry that tells you to keep on doing something.